These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2498314

  • 1. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
    Cohen RL, Niclas J, Lee WM, Wun TC, Crowley CW, Levinson AD, Sadler JE, Shuman MA.
    J Biol Chem; 1989 May 15; 264(14):8375-83. PubMed ID: 2498314
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
    Medcalf RL, Van den Berg E, Schleuning WD.
    J Cell Biol; 1988 Mar 15; 106(3):971-8. PubMed ID: 3126194
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
    Georg B, Helseth E, Lund LR, Skandsen T, Riccio A, Danø K, Unsgaard G, Andreasen PA.
    Mol Cell Endocrinol; 1989 Jan 15; 61(1):87-96. PubMed ID: 2501120
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R.
    J Cell Physiol; 1989 Jul 15; 140(1):119-30. PubMed ID: 2500450
    [Abstract] [Full Text] [Related]

  • 5. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR, Webb AC, Sitrin RG.
    J Immunol; 1988 Oct 15; 141(8):2693-8. PubMed ID: 3139763
    [Abstract] [Full Text] [Related]

  • 6. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
    Quax PH, van Leeuwen RT, Verspaget HW, Verheijen JH.
    Cancer Res; 1990 Mar 01; 50(5):1488-94. PubMed ID: 2105839
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y, Okada M, Noro A, Matsuda M.
    J Biol Chem; 1988 Feb 05; 263(4):1960-9. PubMed ID: 3123483
    [Abstract] [Full Text] [Related]

  • 10. Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells.
    Georg B, Riccio A, Andreasen P.
    Mol Cell Endocrinol; 1990 Aug 20; 72(2):103-10. PubMed ID: 1704320
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
    Heaton JH, Gelehrter TD.
    Mol Endocrinol; 1989 Feb 20; 3(2):349-55. PubMed ID: 2469009
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase.
    Gross TJ, Simon RH, Kelly CJ, Sitrin RG.
    Am J Physiol; 1991 Apr 20; 260(4 Pt 1):L286-95. PubMed ID: 1902065
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N, Belin D, Failly-Crépin C, Vassalli JD.
    Cancer Res; 1987 Jan 15; 47(2):364-70. PubMed ID: 3098408
    [Abstract] [Full Text] [Related]

  • 15. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
    Fukumoto S, Allan EH, Zeheb R, Gelehrter TD, Martin TJ.
    Endocrinology; 1992 Feb 15; 130(2):797-804. PubMed ID: 1733726
    [Abstract] [Full Text] [Related]

  • 16. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
    Sawdey M, Podor TJ, Loskutoff DJ.
    J Biol Chem; 1989 Jun 25; 264(18):10396-401. PubMed ID: 2499579
    [Abstract] [Full Text] [Related]

  • 17. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
    Genton C, Kruithof EK, Schleuning WD.
    J Cell Biol; 1987 Mar 25; 104(3):705-12. PubMed ID: 3102504
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec 25; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.
    van Hinsbergh VW, van den Berg EA, Fiers W, Dooijewaard G.
    Blood; 1990 May 15; 75(10):1991-8. PubMed ID: 2140060
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ.
    J Cell Physiol; 1991 Oct 15; 149(1):34-43. PubMed ID: 1834680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.